SecBot SecBot
8-K ·Filed May 7, 2026

ZTS

Zoetis Inc.
BEARISH
Impact 7/10
Horizondays Processed6mo ago SEC0001555280-26-000021
8-K Item 2.02: Earnings release
Actionable Insight ▼ Bearish

The miss and guidance cut are likely to pressure ZTS shares near term. Monitor the earnings call for commentary on U.S. demand trends and competitive dynamics. The International segment's organic growth and pipeline remain bright spots, but the core U.S. companion animal weakness is a significant headwind.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$87.24
T+0 close · May 7, 2026 · via day close
Latest settled
−11.40%
T+60 · $77.29
Vs SPY
−13.52%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 7 $87.24entry
  2. T+1 · 6mo ago −5.65%α −6.48% · $82.31
  3. T+5 · 6mo ago −14.79%α −16.29% · $74.34
  4. T+20 · 6mo ago −11.06%α −14.20% · $77.59
  5. T+60 · 4mo ago −11.40%α −13.52% · $77.29

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Zoetis Q1 2026 adjusted EPS of $1.53 missed consensus of $1.62 (-5.6%), and FY2026 guidance was lowered to revenue of $9.68-9.96B (from $9.825-10.025B) and adjusted EPS of $6.85-7.00 (from $7.00-7.10). U.S. companion animal revenue fell 11% YoY on weaker demand and competition, partially offset by International growth. The revised outlook signals a more challenging operating environment.

Key Financial Metrics

EPS
$1.53
est $1.62 · -5.6%
Revenue
$2.3B
est $2.3B · -1.6% · +2.9% YoY
Rating
miss
Guidance
$9,680 to $9,960 million
lowered

Key Facts

  • Q1 2026 revenue $2.262B, +3% reported, flat organic operational growth
  • GAAP diluted EPS $1.42, adjusted diluted EPS $1.53
  • Adjusted EPS $1.53 vs consensus $1.62 (miss of 5.6%)
  • FY2026 revenue guidance lowered to $9.680-$9.960B from $9.825-$10.025B
  • FY2026 adjusted EPS guidance lowered to $6.85-$7.00 from $7.00-$7.10
  • U.S. segment revenue fell 8% (companion animal -11%) on price sensitivity and competition
  • International segment revenue up 17% reported (10% organic), aided by ~$100M from fiscal year alignment timing

Financial Impact

Adjusted EPS miss of $0.09 vs consensus; FY2026 revenue midpoint reduced by ~$145M; adjusted EPS guidance midpoint reduced by ~$0.13.

revenueepsguidance

Risk Factors

  • Continued deterioration in U.S. companion animal demand
  • Increased competition in dermatology and parasiticides
  • Macroeconomic pressure on pet owner spending
  • Execution risk in stabilizing U.S. segment performance

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
64% bullish (25 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001555280-26-000021
Document: zts-20260507.htm0001555280-26-000021
Document: 0001555280-26-000021-index-headers.html0001555280-26-000021
Document: 0001555280-26-000021-index.html0001555280-26-000021
Document: 0001555280-26-000021.txt0001555280-26-000021
8-K Data (Synthetic)0001555280-26-000021

Track record

10 reports on ZTS

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +38.10% at T+60 after the Feb 27, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 5, 202611d ago 8-K Bearish 5/10 Entry $82.11 to $79.40 Now $84.39 −2.78% ▲ +3.30% +3.61% vs SPY
  2. Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $79.52 to $79.96 Now $84.39 +6.13% ▲ +0.55% +0.22% vs SPY
  3. Oct 13, 20264w ago 8-K Neutral 2/10 Entry $74.30 to $75.29 Now $84.39 +13.58% ▲ +1.33% +2.41% vs SPY
  4. Oct 8, 20265w ago 8-K Neutral 2/10 Entry $74.81 to $75.65 Now $84.39 +12.81% ▲ +1.12% +1.18% vs SPY
  5. Aug 6, 202614w ago 8-K Bearish 7/10 Entry $77.05 to $72.36 Now $84.39 −9.53% ▲ +6.09% +6.70% vs SPY
  6. May 20, 202625w ago 8-K Neutral 2/10 Entry $79.98 to $81.17 Now $84.39 +5.52% ▲ +1.49% +1.04% vs SPY
  7. May 13, 202626w ago Insider Cluster Neutral 2/10 Entry $75.24 to $73.62 Now $84.39 +12.16% ▼ −2.15% −0.93% vs SPY
  8. May 7, 202627w ago 8-K Bearish 7/10 Viewing Entry $87.24 to $82.31 Now $84.39 +3.27% ▲ +5.65% +6.48% vs SPY
  9. Apr 8, 202631w ago DEFA14A Neutral 2/10 Entry $119.65 to $119.47 Now $84.39 −29.47% ▼ −0.15% −0.72% vs SPY
  10. Feb 27, 202637w ago Court Ruling Bearish 6/10 Entry $127.51 to $124.52 Now $84.39 +33.82% ▲ +2.35% +1.47% vs SPY
Showing 10 of 10

US Market Status

Market Closed · Opens Wed (11h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 7, 2026